Atlas Trials

Personalized Cancer Vaccine (PCV) Strategy in Triple Negative Breast Cancer Patients

Clinical trial NCT07300475 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07300475
Sponsor
Washington University School of Medicine
Status
NOT_YET_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Triple Negative Breast Cancer
Start date
2026-08-01
Primary completion
2030-05-31
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.